Search
for
Sort by
Research 31–60 of 1000+
- Topical calcipotriol mixed with topical steroid versus topical steroid alone in treatment of alopecia areata
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Pharmacotherapy of alopecia areata
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database
- Alternate treatment of alopecia areata with the use of calcipotriol: A prospective study in children versus adults
- Patterns and predictors of Quality-of-Life impairment in alopecia areata: A cross-sectional analysis from south India
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Alopecia universalis. Partial response to tofacitinib
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- 260 Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- [Artículo traducido] Comparación entre la aplicación subcutánea vs. subcutánea e intramuscular combinada de toxina botulínica para el tratamiento de la alopecia androgenética: un ensayo clínico aleatorizado
- Oxidative Stress in Alopecia Areata: A Case–Control Study
- Complete Blood Collection-based Systemic Inflammation Biomarkers as a Severity Biomarker in Alopecia Areata: A Cross-sectional Study
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study
- Serum Levels of Transforming Growth Factor Beta1 (TGF β1) in Patients with Alopecia Areata.
- Assessing the role of stressful life events in the induction and recurrence of alopecia areata: A case-control study
- Dietary Habits in Japanese Patients with Alopecia Areata
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
- Dietary Habits in Japanese Patients with Alopecia Areata
- Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Alopecia Areata in the Indian Subcontinent
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis